2025年7月31日，歐盟食品安全局（EFSA）發(fā)布消息，歐盟食品安全局發(fā)布關(guān)于β-胡蘿卜素（beta-carotene）作為所有動(dòng)物飼料添加劑的授權(quán)更新申請(qǐng)的評(píng)估。
經(jīng)過評(píng)估，專家小組得出結(jié)論，該添加劑在授權(quán)使用條件下對(duì)目標(biāo)物種、消費(fèi)者和環(huán)境都是安全的。在授權(quán)更新的情況下，無需評(píng)估添加劑的功效。部分原文報(bào)道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of beta-carotene (3a160(a)) for the renewal of its authorisation as a nutritional additive for all animal species. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the use of beta-carotene in animal nutrition under the approved conditions remains safe for target species, consumers and the environment. Regarding user safety, the FEEDAP Panel concludes that beta-carotene is not a skin and eye irritant and not a skin sensitiser. One preparation containing 10% beta-carotene was shown not to be a skin sensitiser. However, no conclusions on the safety for the user can be done on any other preparations. The Panel concluded there is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
經(jīng)過評(píng)估，專家小組得出結(jié)論，該添加劑在授權(quán)使用條件下對(duì)目標(biāo)物種、消費(fèi)者和環(huán)境都是安全的。在授權(quán)更新的情況下，無需評(píng)估添加劑的功效。部分原文報(bào)道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of beta-carotene (3a160(a)) for the renewal of its authorisation as a nutritional additive for all animal species. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the use of beta-carotene in animal nutrition under the approved conditions remains safe for target species, consumers and the environment. Regarding user safety, the FEEDAP Panel concludes that beta-carotene is not a skin and eye irritant and not a skin sensitiser. One preparation containing 10% beta-carotene was shown not to be a skin sensitiser. However, no conclusions on the safety for the user can be done on any other preparations. The Panel concluded there is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
